Most Canadians view financial incentives for deceased kidney donation to be acceptable, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). Nearly half of the general public in Canada also find it acceptable for living kidney donation. Studies are now needed to determine whether acceptability of financial incentives translates to more available organs to patients in critical need of a transplant.
Kidney transplantation is the best treatment for patients with kidney failure. Unfortunately, there's a shortage of kidneys available to those in need of a transplant, and donation rates from both living and deceased donors have remained relatively unchanged over the last decade.
Lianne Barnieh, PhD, Braden Manns, MD (University of Calgary, in Canada) and their colleagues looked to see whether financial incentives to increase donation are acceptable and whether they would change individuals' willingness to consider donation. To accomplish this, they administered a questionnaire in the fall of 2011 to 2,004 members of the Canadian public, 339 health professionals, and 268 people with or affected by kidney disease.
Among the major findings:
- 70% and 40% of respondents found financial incentives to be acceptable for deceased and living donors, respectively.
- 45%, 14%, and 27% of the public, health professionals, and people with or affected by kidney disease, respectively, supported monetary payment as a financial incentive for living donors.
- Overall, reimbursement of funeral expenses for deceased donors and a tax break for living donors were the most acceptable forms of financial incentives.
Future research should examine whether financial incentives might increase donations from deceased and living kidney donors.
Explore further: Never too old to donate a kidney?
The article, entitled "Attitudes Toward Strategies to Increase Organ Donation: Views of the General Public and Health Professionals," will appear online on September 27, 2012, doi: 10.2215/CJN.04100412